 | • レポートコード：MRC23Q36032 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、88ページ • 納品方法：Eメール（2-3日） • 産業分類：医療 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界のゲノム編集＆ゲノム工学市場について調査・分析し、世界のゲノム編集＆ゲノム工学市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（クリスプール、タレン、ZFN）、用途別セグメント分析（細胞株工学、動物遺伝子工学、植物遺伝子工学、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Thermo Fisher Scientific、Merck、Horizon Discovery、Genscript、Sangamo Biosciences、Integrated DNA Technologies、Lonza、New England Biolabs、Origene Technologies、Transposagen Biopharmaceuticals、Editas Medicine、Crispr Therapeutics、Tecan Life Sciencesなどが含まれています。世界のゲノム編集＆ゲノム工学市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、ゲノム編集＆ゲノム工学市場規模を推定する際に考慮しました。本レポートは、ゲノム編集＆ゲノム工学の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、ゲノム編集＆ゲノム工学に関するビジネス上の意思決定に役立てることを目的としています。 ・ゲノム編集＆ゲノム工学市場の概要 - ゲノム編集＆ゲノム工学のタイプ別セグメント - 世界のゲノム編集＆ゲノム工学市場規模：タイプ別分析（クリスプール、タレン、ZFN） - ゲノム編集＆ゲノム工学の用途別セグメント - 世界のゲノム編集＆ゲノム工学市場規模：用途別分析（細胞株工学、動物遺伝子工学、植物遺伝子工学、その他） - 世界のゲノム編集＆ゲノム工学市場規模予測（2018年-2029年） ・ゲノム編集＆ゲノム工学市場の成長トレンド - ゲノム編集＆ゲノム工学の地域別市場規模（2018年-2029年） - ゲノム編集＆ゲノム工学市場ダイナミクス - ゲノム編集＆ゲノム工学の業界動向 - ゲノム編集＆ゲノム工学市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：クリスプール、タレン、ZFN - 世界のゲノム編集＆ゲノム工学のタイプ別市場規模（2018年-2023年） - 世界のゲノム編集＆ゲノム工学のタイプ別市場規模（2024年-2029年） ・用途別セグメント：細胞株工学、動物遺伝子工学、植物遺伝子工学、その他 - 世界のゲノム編集＆ゲノム工学の用途別市場規模（2018年-2023年） - 世界のゲノム編集＆ゲノム工学の用途別市場規模（2024年-2029年） ・ゲノム編集＆ゲノム工学の地域別市場規模 - 北米のゲノム編集＆ゲノム工学市場規模（2018年-2029年） - アメリカのゲノム編集＆ゲノム工学市場規模（2018年-2029年） - ヨーロッパのゲノム編集＆ゲノム工学市場規模（2018年-2029年） - アジア太平洋のゲノム編集＆ゲノム工学市場規模（2018年-2029年） - 中国のゲノム編集＆ゲノム工学市場規模（2018年-2029年） - 日本のゲノム編集＆ゲノム工学市場規模（2018年-2029年） - 韓国のゲノム編集＆ゲノム工学市場規模（2018年-2029年） - インドのゲノム編集＆ゲノム工学市場規模（2018年-2029年） - オーストラリアのゲノム編集＆ゲノム工学市場規模（2018年-2029年） - 中南米のゲノム編集＆ゲノム工学市場規模（2018年-2029年） - 中東・アフリカのゲノム編集＆ゲノム工学市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Thermo Fisher Scientific、Merck、Horizon Discovery、Genscript、Sangamo Biosciences、Integrated DNA Technologies、Lonza、New England Biolabs、Origene Technologies、Transposagen Biopharmaceuticals、Editas Medicine、Crispr Therapeutics、Tecan Life Sciences ・アナリストの観点/結論 ・調査方法とデータソース |
Genome editing technology refers to the ability of human to “edit” the target gene, such as the deletion and addition of specific DNA fragments.
Highlights
The global Genome Editing and Genome Engineering market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Genome Editing and Genome Engineering is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Genome Editing and Genome Engineering is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Genome Editing and Genome Engineering in Cell Line Engineering is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Genome Editing and Genome Engineering include Thermo Fisher Scientific, Merck, Horizon Discovery, Genscript, Sangamo Biosciences, Integrated DNA Technologies, Lonza, New England Biolabs and Origene Technologies, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Genome Editing and Genome Engineering, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genome Editing and Genome Engineering.
The Genome Editing and Genome Engineering market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Genome Editing and Genome Engineering market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Genome Editing and Genome Engineering companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Thermo Fisher Scientific
Merck
Horizon Discovery
Genscript
Sangamo Biosciences
Integrated DNA Technologies
Lonza
New England Biolabs
Origene Technologies
Transposagen Biopharmaceuticals
Editas Medicine
Crispr Therapeutics
Tecan Life Sciences
Segment by Type
CRISPR
TALEN
ZFN
Segment by Application
Cell Line Engineering
Animal Genetic Engineering
Plant Genetic Engineering
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Genome Editing and Genome Engineering companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genome Editing and Genome Engineering Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 CRISPR
1.2.3 TALEN
1.2.4 ZFN
1.3 Market by Application
1.3.1 Global Genome Editing and Genome Engineering Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Cell Line Engineering
1.3.3 Animal Genetic Engineering
1.3.4 Plant Genetic Engineering
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Genome Editing and Genome Engineering Market Perspective (2018-2029)
2.2 Genome Editing and Genome Engineering Growth Trends by Region
2.2.1 Global Genome Editing and Genome Engineering Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Genome Editing and Genome Engineering Historic Market Size by Region (2018-2023)
2.2.3 Genome Editing and Genome Engineering Forecasted Market Size by Region (2024-2029)
2.3 Genome Editing and Genome Engineering Market Dynamics
2.3.1 Genome Editing and Genome Engineering Industry Trends
2.3.2 Genome Editing and Genome Engineering Market Drivers
2.3.3 Genome Editing and Genome Engineering Market Challenges
2.3.4 Genome Editing and Genome Engineering Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Genome Editing and Genome Engineering Players by Revenue
3.1.1 Global Top Genome Editing and Genome Engineering Players by Revenue (2018-2023)
3.1.2 Global Genome Editing and Genome Engineering Revenue Market Share by Players (2018-2023)
3.2 Global Genome Editing and Genome Engineering Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Genome Editing and Genome Engineering Revenue
3.4 Global Genome Editing and Genome Engineering Market Concentration Ratio
3.4.1 Global Genome Editing and Genome Engineering Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genome Editing and Genome Engineering Revenue in 2022
3.5 Genome Editing and Genome Engineering Key Players Head office and Area Served
3.6 Key Players Genome Editing and Genome Engineering Product Solution and Service
3.7 Date of Enter into Genome Editing and Genome Engineering Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Genome Editing and Genome Engineering Breakdown Data by Type
4.1 Global Genome Editing and Genome Engineering Historic Market Size by Type (2018-2023)
4.2 Global Genome Editing and Genome Engineering Forecasted Market Size by Type (2024-2029)
5 Genome Editing and Genome Engineering Breakdown Data by Application
5.1 Global Genome Editing and Genome Engineering Historic Market Size by Application (2018-2023)
5.2 Global Genome Editing and Genome Engineering Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Genome Editing and Genome Engineering Market Size (2018-2029)
6.2 North America Genome Editing and Genome Engineering Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Genome Editing and Genome Engineering Market Size by Country (2018-2023)
6.4 North America Genome Editing and Genome Engineering Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Genome Editing and Genome Engineering Market Size (2018-2029)
7.2 Europe Genome Editing and Genome Engineering Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Genome Editing and Genome Engineering Market Size by Country (2018-2023)
7.4 Europe Genome Editing and Genome Engineering Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Genome Editing and Genome Engineering Market Size (2018-2029)
8.2 Asia-Pacific Genome Editing and Genome Engineering Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Genome Editing and Genome Engineering Market Size by Region (2018-2023)
8.4 Asia-Pacific Genome Editing and Genome Engineering Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Genome Editing and Genome Engineering Market Size (2018-2029)
9.2 Latin America Genome Editing and Genome Engineering Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Genome Editing and Genome Engineering Market Size by Country (2018-2023)
9.4 Latin America Genome Editing and Genome Engineering Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Genome Editing and Genome Engineering Market Size (2018-2029)
10.2 Middle East & Africa Genome Editing and Genome Engineering Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Genome Editing and Genome Engineering Market Size by Country (2018-2023)
10.4 Middle East & Africa Genome Editing and Genome Engineering Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Genome Editing and Genome Engineering Introduction
11.1.4 Thermo Fisher Scientific Revenue in Genome Editing and Genome Engineering Business (2018-2023)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Genome Editing and Genome Engineering Introduction
11.2.4 Merck Revenue in Genome Editing and Genome Engineering Business (2018-2023)
11.2.5 Merck Recent Development
11.3 Horizon Discovery
11.3.1 Horizon Discovery Company Detail
11.3.2 Horizon Discovery Business Overview
11.3.3 Horizon Discovery Genome Editing and Genome Engineering Introduction
11.3.4 Horizon Discovery Revenue in Genome Editing and Genome Engineering Business (2018-2023)
11.3.5 Horizon Discovery Recent Development
11.4 Genscript
11.4.1 Genscript Company Detail
11.4.2 Genscript Business Overview
11.4.3 Genscript Genome Editing and Genome Engineering Introduction
11.4.4 Genscript Revenue in Genome Editing and Genome Engineering Business (2018-2023)
11.4.5 Genscript Recent Development
11.5 Sangamo Biosciences
11.5.1 Sangamo Biosciences Company Detail
11.5.2 Sangamo Biosciences Business Overview
11.5.3 Sangamo Biosciences Genome Editing and Genome Engineering Introduction
11.5.4 Sangamo Biosciences Revenue in Genome Editing and Genome Engineering Business (2018-2023)
11.5.5 Sangamo Biosciences Recent Development
11.6 Integrated DNA Technologies
11.6.1 Integrated DNA Technologies Company Detail
11.6.2 Integrated DNA Technologies Business Overview
11.6.3 Integrated DNA Technologies Genome Editing and Genome Engineering Introduction
11.6.4 Integrated DNA Technologies Revenue in Genome Editing and Genome Engineering Business (2018-2023)
11.6.5 Integrated DNA Technologies Recent Development
11.7 Lonza
11.7.1 Lonza Company Detail
11.7.2 Lonza Business Overview
11.7.3 Lonza Genome Editing and Genome Engineering Introduction
11.7.4 Lonza Revenue in Genome Editing and Genome Engineering Business (2018-2023)
11.7.5 Lonza Recent Development
11.8 New England Biolabs
11.8.1 New England Biolabs Company Detail
11.8.2 New England Biolabs Business Overview
11.8.3 New England Biolabs Genome Editing and Genome Engineering Introduction
11.8.4 New England Biolabs Revenue in Genome Editing and Genome Engineering Business (2018-2023)
11.8.5 New England Biolabs Recent Development
11.9 Origene Technologies
11.9.1 Origene Technologies Company Detail
11.9.2 Origene Technologies Business Overview
11.9.3 Origene Technologies Genome Editing and Genome Engineering Introduction
11.9.4 Origene Technologies Revenue in Genome Editing and Genome Engineering Business (2018-2023)
11.9.5 Origene Technologies Recent Development
11.10 Transposagen Biopharmaceuticals
11.10.1 Transposagen Biopharmaceuticals Company Detail
11.10.2 Transposagen Biopharmaceuticals Business Overview
11.10.3 Transposagen Biopharmaceuticals Genome Editing and Genome Engineering Introduction
11.10.4 Transposagen Biopharmaceuticals Revenue in Genome Editing and Genome Engineering Business (2018-2023)
11.10.5 Transposagen Biopharmaceuticals Recent Development
11.11 Editas Medicine
11.11.1 Editas Medicine Company Detail
11.11.2 Editas Medicine Business Overview
11.11.3 Editas Medicine Genome Editing and Genome Engineering Introduction
11.11.4 Editas Medicine Revenue in Genome Editing and Genome Engineering Business (2018-2023)
11.11.5 Editas Medicine Recent Development
11.12 Crispr Therapeutics
11.12.1 Crispr Therapeutics Company Detail
11.12.2 Crispr Therapeutics Business Overview
11.12.3 Crispr Therapeutics Genome Editing and Genome Engineering Introduction
11.12.4 Crispr Therapeutics Revenue in Genome Editing and Genome Engineering Business (2018-2023)
11.12.5 Crispr Therapeutics Recent Development
11.13 Tecan Life Sciences
11.13.1 Tecan Life Sciences Company Detail
11.13.2 Tecan Life Sciences Business Overview
11.13.3 Tecan Life Sciences Genome Editing and Genome Engineering Introduction
11.13.4 Tecan Life Sciences Revenue in Genome Editing and Genome Engineering Business (2018-2023)
11.13.5 Tecan Life Sciences Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details